Igea A - Search Results

1

Combined Inhibition of FOSL-1 and YAP Using siRNA-Lipoplexes Reduces the Growth of Pancreatic Tumor.

Diego-González L, Fernández-Carrera A, Igea A, Martínez-Pérez A, Real Oliveira MECD, Gomes AC, Guerra C, Barbacid M, González-Fernández Á, Simón-Vázquez R. Diego-González L, et al. Among authors: igea a. Cancers (Basel). 2022 Jun 24;14(13):3102. doi: 10.3390/cancers14133102. Cancers (Basel). 2022. PMID: 35804874 Free PMC article.

2

Changes in the Immune Phenotype and Gene Expression Profile Driven by a Novel Tuberculosis Nanovaccine: Short and Long-Term Post-immunization.

Martínez-Pérez A, Igea A, Estévez O, Ferreira CM, Torrado E, Castro AG, Fernández C, Spetz AL, Adam L, López González M, Singh M, Reljic R, González-Fernández Á. Martínez-Pérez A, et al. Among authors: igea a. Front Immunol. 2021 Jan 28;11:589863. doi: 10.3389/fimmu.2020.589863. eCollection 2020. Front Immunol. 2021. PMID: 33584654 Free PMC article.

3

Central Role of Semaphorin 3B in a Serum-Induced Arthritis Model and Reduced Levels in Patients With Rheumatoid Arthritis.

Igea A, Carvalheiro T, Malvar-Fernández B, Martinez-Ramos S, Rafael-Vidal C, Niemantsverdriet E, Varadé J, Fernández-Carrera A, Jimenez N, McGarry T, Rodriguez-Trillo A, Veale D, Fearon U, Conde C, Pego-Reigosa JM, González-Fernández Á, Reedquist KA, Radstake TRDJ, van der Helm-Van Mil A, García S. Igea A, et al. Arthritis Rheumatol. 2022 Jun;74(6):972-983. doi: 10.1002/art.42065. Epub 2022 Apr 13. Arthritis Rheumatol. 2022. PMID: 35001548 Free PMC article.

4

Pharmacological inhibition of p38 MAPK reduces tumor growth in patient-derived xenografts from colon tumors.

Gupta J, Igea A, Papaioannou M, Lopez-Casas PP, Llonch E, Hidalgo M, Gorgoulis VG, Nebreda AR. Gupta J, et al. Among authors: igea a. Oncotarget. 2015 Apr 20;6(11):8539-51. doi: 10.18632/oncotarget.3816. Oncotarget. 2015. PMID: 25890501 Free PMC article.

5

Editorial: Reprogramming Stromal Cells in Chronic Inflammation and Cancer.

Igea A, Martin OCB, Cooks T, Pateras IS. Igea A, et al. Front Cell Dev Biol. 2021 Nov 5;9:728439. doi: 10.3389/fcell.2021.728439. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34858972 Free PMC article. No abstract available.

6

Inhibition of p38 MAPK sensitizes tumour cells to cisplatin-induced apoptosis mediated by reactive oxygen species and JNK.

Pereira L, Igea A, Canovas B, Dolado I, Nebreda AR. Pereira L, et al. Among authors: igea a. EMBO Mol Med. 2013 Nov;5(11):1759-74. doi: 10.1002/emmm.201302732. Epub 2013 Sep 24. EMBO Mol Med. 2013. PMID: 24115572 Free PMC article.

7

Dual function of p38α MAPK in colon cancer: suppression of colitis-associated tumor initiation but requirement for cancer cell survival.

Gupta J, del Barco Barrantes I, Igea A, Sakellariou S, Pateras IS, Gorgoulis VG, Nebreda AR. Gupta J, et al. Among authors: igea a. Cancer Cell. 2014 Apr 14;25(4):484-500. doi: 10.1016/j.ccr.2014.02.019. Epub 2014 Mar 27. Cancer Cell. 2014. PMID: 24684847 Free article.

8

The Stress Kinase p38α as a Target for Cancer Therapy.

Igea A, Nebreda AR. Igea A, et al. Cancer Res. 2015 Oct 1;75(19):3997-4002. doi: 10.1158/0008-5472.CAN-15-0173. Epub 2015 Sep 16. Cancer Res. 2015. PMID: 26377941 Review.

9

Expression and functional validation of new p38α transcriptional targets in tumorigenesis.

Swat A, Dolado I, Igea A, Gomez-Lopez G, Pisano DG, Cuadrado A, Nebreda AR. Swat A, et al. Among authors: igea a. Biochem J. 2011 Mar 15;434(3):549-58. doi: 10.1042/BJ20101410. Biochem J. 2011. PMID: 21226672

10

Targeting of non-oncogene addiction.

Igea A, Gupta J, Nebreda AR. Igea A, et al. Aging (Albany NY). 2015 Aug;7(8):525-6. doi: 10.18632/aging.100796. Aging (Albany NY). 2015. PMID: 26298432 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

32 results

Search Page